GSA Capital Partners LLP Lowers Stock Position in Aspen Aerogels, Inc. (NYSE:ASPN)

GSA Capital Partners LLP lessened its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 62.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 24,860 shares of the construction company's stock after selling 41,351 shares during the quarter. GSA Capital Partners LLP's holdings in Aspen Aerogels were worth $688,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Peregrine Asset Advisers Inc. acquired a new stake in Aspen Aerogels in the 3rd quarter worth about $1,520,000. Sigma Planning Corp acquired a new position in shares of Aspen Aerogels in the 3rd quarter valued at approximately $274,000. Mesirow Financial Investment Management Inc. bought a new stake in shares of Aspen Aerogels during the 3rd quarter valued at approximately $252,000. Bridgewater Advisors Inc. grew its holdings in shares of Aspen Aerogels by 37.8% during the 3rd quarter. Bridgewater Advisors Inc. now owns 77,357 shares of the construction company's stock valued at $2,142,000 after purchasing an additional 21,218 shares during the last quarter. Finally, Pursue Wealth Partners LLC bought a new stake in shares of Aspen Aerogels during the 3rd quarter valued at approximately $222,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ASPN. TD Cowen boosted their target price on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a "buy" rating in a report on Tuesday, August 20th. Roth Mkm reduced their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a report on Friday, November 8th. Piper Sandler reduced their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a report on Tuesday, October 22nd. Benchmark reissued a "buy" rating and set a $14.00 target price on shares of Aspen Aerogels in a report on Thursday, August 8th. Finally, Barclays reduced their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 12th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels has a consensus rating of "Moderate Buy" and a consensus target price of $28.70.

Aspen Aerogels Stock Up 1.5 %

Shares of NYSE ASPN traded up $0.22 during trading on Monday, hitting $14.50. The stock had a trading volume of 3,386,245 shares, compared to its average volume of 1,609,411. Aspen Aerogels, Inc. has a 12 month low of $10.19 and a 12 month high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.82. The company has a market capitalization of $1.19 billion, a PE ratio of 1,428.00 and a beta of 2.21. The firm has a fifty day moving average of $22.04 and a two-hundred day moving average of $24.72.

Insider Activity at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares of the company's stock, valued at approximately $626,610.60. This represents a 60.96 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 11.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.